NEPH
Nephros Inc
NASDAQ: NEPH · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$3.24
-2.41% today
Updated 2026-04-29
Market cap
$34.38M
P/E ratio
29.36
P/S ratio
1.83x
EPS (TTM)
$0.11
Dividend yield
—
52W range
$2 – $6
Volume
0.0M
Nephros Inc (NEPH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.24
12-Month target
$2.31
2030 Target
—
Intrinsic (DCF)
$6.68
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 6.36%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.